# CUVRIOR
> **NDA215760** · New Drug Application · Sponsor: ORPHALAN · Approved 2022-04-28
## Drug
- **FDA Application Number:** NDA215760
- **Application type:** New Drug Application
- **Brand name:** CUVRIOR
- **Generic name:** TRIENTINE TETRAHYDROCHLORIDE
- **Active ingredients:** TRIENTINE TETRAHYDROCHLORIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ORPHALAN
- **Manufacturer:** Orphalan SA
- **First approval:** 2022-04-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215760)
---
*MORVS · CC0 1.0*